Influence of approach on outcome in radiofrequency ablation of liver tumors

Surgical Oncology

Volumn 17, Issue 4, 2008, Pages 295-299

  Burdio, Fernando ^a   Mulier, Stefaan ^b   Navarro, Ana ^c   Figueras, Juan ^d   Berjano, Enrique ^e   Poves, Ignasi ^a   Grande, Luis ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Liver tumors; Radiofrequency ablation

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER SURGERY; HUMAN; LIVER RESECTION; LIVER TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL APPROACH; TREATMENT OUTCOME;

CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; TREATMENT OUTCOME;

EID: 53049096959     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.03.002     Document Type: Review

References (65)

1. Tanabe K.K., Curley S.A., Dodd G.D., Siperstein A.E., and Goldberg S.N. Radiofrequency ablation. The experts weigh in. Cancer 100 3 (2003) 641-650
2. Ahmad S.A. Limitations of radiofrequency in treating liver metastases. A lesson in geometry. Ann Surg Oncol 11 4 (2004) 358-359
3. Montgomery R.S., Rahal A., Dodd G., Leyendecker J.R., and Hubbard L.G. Radiofrequency ablation of hepatic tumors: variability of lesion size using a single ablation device. AJR 182 (2004) 657-661
4. Stippel D.L., Brochlagen H.G., Arenja M., Hunkemöller J., Hölscher A.H., and Beckurts K.T. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol 11 4 (2004) 420-425
5. Breitenbuch P., Köhl G., Guba M., Geissler E., Jauch K.W., and Steinbauer M. Thermoablation of colorectal liver metastases promotes proliferation of residual intrahepatic neoplastic cells. Surgery 138 5 (2005) 882-887
6. Nikfarjam M., Muralidharan V., and Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 139 1 (2006) 73-81
7. Burdío F., Navarro A., Güemes A., Sousa R., Tejero E., and Lozano R. Does thermal ablation promote liver metastases progression more than resection?. Surgery 140 3 (2006) 479-480
8. Meredith K., Haemmerich D., Qi C., and Mahvi D. Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Ann Surg 245 5 (2007) 771-776
9. Zerbini A., Pilli M., Penna A., Schianchi C., Molinari A., Schivazappa S., et al. Radiofrequency thermal ablation of hepatocelullar carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66 2 (2006) 1139-1146
10. Frich L., Bornland K., Pettersen S., Clausen O.P., and Gladhaug I.P. Increased activity of matrix metalloproteinase 2 and 9 after hepatic radiofrequency ablation. J Surg Res 135 (2006) 297-304
11. NICE. Radiofrequency ablation for the treatment of colorectal metastases in the liver (2004), National Institute for Clinical Excellence, United Kingdom
12. The Cochrane Collaboration. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases 2007.
13. Ruers T.J., De Jong K.P., and Jzermans J.N. Radiofrequency for the treatment of liver tumors. Dig Surg 22 (2005) 24-253
14. Livraghi T., Solbiati L., Meloni M.F., Gazelle G.S., Halpern E.F., and Goldberg S.N. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 226 (2003) 441-451
15. Casaril A., Abu Hilal M.A., Harb A., Campagnaro T., Mansuelo G., and Nicoli N. The safety of radiofrequency termal in treatment of liver malignancies. EJSO (2007) Jul 26; [Epub ahead of print]
16. Cho Y.K., Rhim H., Ahn Y.S., Kim M.Y., and Lim H.K. Percutaneous radiofrequency ablation therapy of hepatocelullar carcinoma using multitined electrodes: comparison of subcapsular and nonsubcapsular tumors. AJR 186 (2006) S269-S274
17. Rose S.C., Hassanein T.I., Bouvet M., Hart M.E., Khanna A., and Saville M.W. Delivery of radiofrequency ablation probes to the targeted liver malignancy: Using all the players on the field. JVIR 13 10 (2003) 1060-1061
18. Elias D., Goharin A., El Otmany A., Taieb J., Duvillard P., Lasser P., et al. Usefulness of intraoperative radiofrequency thermoablation of liver tumors associaated or not with hepatectomy. EJSO 26 (2000) 763-769
19. Belghiti J., and Vilgrain V. Radiofrequency ablation of hepatocelullar carcinoma: who should do it?. Ann Surg Oncol 12 8 (2005) 1-2
20. Mulier S., Ni Y., Jamart J., Ruers T., Marchal G., and Michel L. Local recurrences after hepatic radiofrequency (RF) coagulation. Multivariate meta-analysis and review of contributing factors. Ann Surg 242 2 (2005) 158-171
21. Mulier S., Ni Y., Jamart J., Michel L., Marchal G., and Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: Time for a randomized trial?. Ann Surg Oncol 15 1 (2008) 144-157
22. Khan M.R., Poon R.T.P., Ng K.K., Chan A.C., Yuen J., Tung H., et al. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocelullar carcinoma. Arch Surg 142 12 (2007) 1136-1143
23. Curley S.A., Marra P., Beaty K., Ellis L.M., Vauthery J.N., Abdalla E.K., et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239 4 (2004) 450-458
24. Poon R.T., Ng K.K., Lam C.M., Ai V., Yuen J., Fan S.T., et al. Learning curve for radiofrequency ablation of liver tumors. Prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 239 4 (2004) 441-448
25. Mulier S., Mulier P., Ni Y., Miao Y., Dupas B., Marchal G., et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg 89 (2002) 1206-1222
26. Curley S.A., Izzo F., Ellis L.M., Vauthery N.J., and Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232 3 (2000) 381-391
27. Laurent A., Cherqui D., Lesurtel M., Brunetti F., Tayar C., and Fagniez P.L. Laparoscopic liver resection for subcapsular hepatocelullar carcinoma complicating chronic liver disease. Arch Surg 138 (2003) 763-769
28. Santambrogio R., Podda M., Zuin M., Bertolini E., Bruno S., Cornalba G.P., et al. Safety and efficacy of laparoscopic radiofrequency of hepatocelullar carcinoma in patients with liver cirrhosis. Surg Endosc 17 (2003) 1826-1832
29. Mazzaglia P.J., Berber E., Milas M., and Siperstein A.E. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142 1 (2007) 10-18
30. Schemmer P., Enomoto N., Bradford B.U., Bunzendahl H., Raleigh J.A., Lemasters J.J., et al. Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in rats. Am J Physiol Gastrointest Liver Physiol 280 (2001) G1076-G1082
31. Helton W.S. Minimizing complications with radiofrequency ablation for liver cancer. The importance of properly controlled clinical trials and standardized reporting. Ann Surg 239 4 (2004) 459-463
32. Hildebrand P., Leibeke T., Kleemann M., Mirow L., Birth M., Bruch H.P., et al. Influence of operator experience in radiofrequency ablation of malignant liver tumors on the treatment outcome. EJSO 32 (2006) 430-434
33. Patterson E.J., Scudamore C.H., Owen E.J., Nagy A.G., and Buczkowski A.K. Radiofrequency ablation of porcine liver in vivo. Effects of blood flow and treatment time on lesion size. Ann Surg 227 4 (1998) 559-565
34. Goldberg S.N., Hahn P.F., Tanabe K.K., Mueller P.R., Schima W., Athanasoulis C.A., et al. Percutaneous radiofrequency tissue ablation: Does perfusion mediated tissue cooling limit coagulation necrosis?. JVIR 209 (1998) 761-767
35. Lu D.S., Raman S.S., Vodopich D., Wang M., Sayre J., and Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink effect". AJR 178 (2002) 47-51
36. Wiersinga W.J., Jansen M.C., Straatsburg H., Davids P.H., Klaase J.M., Gouma D.J., et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 90 (2003) 306-312
37. Chang C.K., Hendy M.P., Smith M., Recht M.H., and Welling R.E. Radiofrequency ablation of the porcine liver with complete hepatic vascular occlusion. Ann Surg Oncol 9 6 (2002) 594-598
38. Nikfarjam M., Muralidharan V., and Christophi C. Mechanisms of focal heat destruction of liver tumors. JSR 127 (2005) 208-223
39. Kuvshinoff B.W., and Ota D.M. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 132 (2002) 605-612
40. Curley S.A., Izzo F., Delrio P., Ellis L.M., Gancho J., Vallote P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Results in 123 patients. Ann Surg 230 1 (1999) 1-8
41. Washburn W.K., Dodd G.D., Kohlmeier R.E., McCoy V.A., Napier D., Hubbard L.G., et al. Radiofrequency tissue ablation: Effect of hepatic blood flow occlusion on thermal injuries produced in cirrhotic livers. Ann Surg Oncol 10 7 (2003) 773-777
42. Wood T.F., Rose M., Chung M., Allegra D.P., Foshag L.J., and Bilchik A.J. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations and complications. Ann Surg Oncol 7 8 (2000) 593-600
43. Lu D.S., Yu N.C., Raman S.S., Limanond P., Lassman C., and Murray K. Radiofrequency ablation of hepatocelullar carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 235 (2005) 954-960
44. Scott D.J., Fleming J.B., Watumull L.M., Lindberg G., Tesfay S.T., and Jones D.B. The effect of hepatic inflow occlusion on laparoscopic radiofrequency ablation using simulated tumors. Surg Endosc 16 (2002) 1286-1291
45. Goletti O., Lencioni R., Armillotta N., Puglisi A., Lippolis P.V., Cioni D., et al. Laparoscopic radiofrequency thermal ablation of hepatocarcinoma: preliminary experience. Surg Laparosc Endosc Percutan Tech 10 5 (2000) 284-290
46. Rossi S., Garbagnati F., Lencioni R., Allgaier H.P., Marchiano A., Fornari F., et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocelullar carcinoma after occlusion of tumor supply. Radiology 217 (2000) 119-126
47. Yamasaki T., Kurokawa F., Shirahashi H., Kusano N., Hironaka K., and Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocelullar carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 95 11 (2002) 2353-2360
48. Sugimori K., Morimoto M., Shirato K., Kokawa A., Tomita N., Saito T., et al. Radiofrequency ablation in a pig liver model: effect of transcatheter arterial embolization on coagulation diameter and histologic characteristics. Hepatol Res 24 (2002) 164-173
49. Horkan C., Ahmed M., Liu Z., Gazelle G.S., Solazzo S.A., Kruskal J.B., et al. Radiofrequency ablation: effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. JVIR 15 3 (2004) 269-274
50. Ng K.K.C., Lam C.M., Poon R.T.P., Shek T.W., Fan S.T., and Wong J. Delayed vein thrombosis after experimental radiforequency ablation near the main portal vein. Br J Surg 91 (2004) 632-639
51. Ng K.K., Poon R.T., Lam C.M., Yuen J., Tso W.K., and Fan S.T. Efficacy and safety of radiofrequency ablation for perivascular hepatocelular carcinoma without hepatic inflow occlusion. Br J Surg 93 (2006) 440-447
52. Frich L., Hol P.K., Roy S., Mala T., Edwin B., and Clausen O.P. Experimental hepatic radiofrequency ablation using wet electrodes: electrode-to-vessel distance is a significant predictor for delayed portal vein thrombosis. Eur Radiol 16 9 (2006) 1990-1999
53. Baere T., Risse O., Kuoch V., Dromain C., Sengel C., Smayra T., et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR 181 (2003) 695-700
54. Marchal F., Elias D., Rauch P., Leroux A., Stines J., Verhaeghe J.L., et al. Prevention of biliary lesions that may occur during radiofrequency ablation of the liver. Study on the pig. Ann Surg 243 1 (2006) 82-88
55. Teratani T., Yoshida, Shiina S., Obi S., Sato S., Tateishi R., et al. Radiofrequency ablation for hepatocelullar carcinoma in so-called high risk locations. Hepatology 43 5 (2006) 1101-1108
56. Bleicher R.J., Allegra D.P., Nora D.T., Word T.F., Foshag L.J., and Bilchik A.J. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 10 1 (2003) 52-58
57. Lencioni R., Della Pina C., and Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 30 4 (2005) 401-408
58. Antoch G., Kuehl H., Vogt F.M., Debatin J.F., and Stattaus J. Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. JVIR 13 (2002) 1155-1161
59. Elias D., Sideris L., Pocard M., De Baere T., Dromain C., Lassau N., et al. Incidence of unsuspected and treatable metastasic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol 12 4 (2005) 298-302
60. Poon R.T.P., Ng K.K., Lam C.M., Ai V., Yuen J., and Fan S.T. Effectiveness of radiofrequency ablation for hepatocelullar carcinomas larger than 3 cm in diameter. Arch Surg 139 (2004) 281-287
61. Chen M.H., Yang W., Yan K., Hou Y.B., Dai Y., Gao, et al. Radiofrequency ablation of problematically located hepatocelullar carcinoma: tailored apporach. Abdom Imaging (2007) PMID: 17639375
62. Scaife C.L., Ng C.S., Ellis L.M., Vauthey J.N., Chansangavej C., and Curley S.A. Accuracy of preoperative imaging of hepatic tumors with helical computed tomgraphy. Ann Surg Oncol 13 4 (2006) 542-546
63. Amersi F.F., McElrath-Garza A., Ahmad A., Zogakis T., Allegra D.P., Krasne R., et al. Long-term survival alter radiofrequency ablation of complex unresectable liver tumors. Arch Surg 141 (2006) 581-588
64. Sutherland L.M., Williams J.A.R., Padbury R.T.A., Gotley D.C., Stokes B., and Maddern G.J. Radiofrequency ablation of liver tumors. A systematic review. Arch Surg 141 (2006) 181-190
65. Raut C.P., Izzo F., Marra P., Ellis L.M., Vauthey J.N., Cremona F., et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocelullar carcinoma in patients with cirrhosis. Ann Surg Oncol 12 8 (2005) 1-13